Basic Information
| LncRNA/CircRNA Name | lncRNA-ATB |
| Synonyms | LOC109207222 |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR |
| Sample | breast cancer tissues |
| Expression Pattern | down-regulated |
| Function Description | LncRNA-ATB has been shown to be downregulated in about two third of tumor samples compared with their ANCTs. A significant association has been found between ZEB1 expression and Ki-67 status. In addition, we demonstrated a correlation between expression of lncRNA-ATB and ZEB1 in tumor samples and not in ANCTs. |
| Pubmed ID | 28598827 |
| Year | 2017 |
| Title | Expression analysis of long non-coding ATB and its putative target in breast cancer |
External Links
| Links for lncRNA-ATB | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |